Literature DB >> 1540219

Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class mu gene detected by polymerase chain reaction.

J Brockmöller1, D Gross, R Kerb, N Drakoulis, I Roots.   

Abstract

Glutathione S-transferase (GST) class Mu activity was determined in 145 unrelated hospital patients in Berlin by measuring their conjugation activity towards the specific substrate trans-stilbene oxide (TSO) with two substrate concentrations (50 and 250 microM) in homogenates prepared from lymphocytes. Eighty individuals (55.2%) had an activity lower than 10 pmol/min/10(6) lymphocytes and were classified as GST class Mu deficient. In 142 of 145 cases, phenotype was confirmed by the results of a genotyping procedure using the polymerase chain reaction technique. Two fragments of 273 and about 650 bp including one and two introns, respectively, could always be amplified from genomic DNA in individuals with high GST class Mu activity and could not be amplified in persons with impaired glutathione-TSO conjugation activity. This indicates that persons with low activity carry a large deletion mutation within the GST class Mu gene. The enzymatically determined antimode between low and high activity determined as 10 pmol/min/1 million lymphocytes in the assay with 50 microM TSO could be clearly confirmed by genotyping.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540219     DOI: 10.1016/0006-2952(92)90591-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  16 in total

Review 1.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

2.  Glutathione S-transferase copy number variation alters lung gene expression.

Authors:  M W Butler; N R Hackett; J Salit; Y Strulovici-Barel; L Omberg; J Mezey; R G Crystal
Journal:  Eur Respir J       Date:  2011-02-24       Impact factor: 16.671

3.  Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A,B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus.

Authors:  A A Fryer; L Zhao; J Alldersea; W R Pearson; R C Strange
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

4.  Glutathione S-transferase mu genotype (GSTM1*0) in Alzheimer's patients with tacrine transaminitis.

Authors:  V J Green; M Pirmohamed; N R Kitteringham; M J Knapp; B K Park
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

5.  Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity.

Authors:  Lena Ernstgård; Margareta Warholm; Gunnar Johanson
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

6.  Magnesium Adenosine 5[prime]-Triphosphate-Energized Transport of Glutathione-S-Conjugates by Plant Vacuolar Membrane Vesicles.

Authors:  Z. S. Li; Y. Zhao; P. A. Rea
Journal:  Plant Physiol       Date:  1995-04       Impact factor: 8.340

7.  Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.

Authors:  I Roots; J Brockmöller; N Drakoulis; R Loddenkemper
Journal:  Clin Investig       Date:  1992 Mar-Apr

8.  Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology.

Authors:  P David Josephy
Journal:  Hum Genomics Proteomics       Date:  2010-06-13

9.  Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms.

Authors:  Daphne W Bell; Brian W Brannigan; Keitaro Matsuo; Dianne M Finkelstein; Raffaella Sordella; Jeff Settleman; Tetsuya Mitsudomi; Daniel A Haber
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

10.  Genetic polymorphism for glutathione-S-transferase mu in asbestos cement workers.

Authors:  K Jakobsson; A Rannug; A K Alexandrie; L Rylander; M Albin; L Hagmar
Journal:  Occup Environ Med       Date:  1994-12       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.